Luxottica Reports Strong Retail and Wholesale Q3

By Staff
Friday, October 31, 2014 12:23 AM MILAN, Italy— Luxottica Group (NYSE: LUX) reported strong sales in its wholesale and retail sectors for the third fiscal quarter, ending Sept. 30.

Hoya Reports Strong Growth in Second Quarter

By Staff
Friday, October 31, 2014 12:20 AM TOKYO— Hoya Corp. (TOKYO: 7741) reported a significant upturn in revenue and profit for the second quarter ended Sept. 30, 2014. During the quarter, revenues totaled 121,242 million yen, increasing by 18.6 percent from the same period the previous year.

Luxottica Reports Strong Retail and Wholesale Q3, Officially Confirms Two Co-CEOS, Names New CFO

By Staff
Wednesday, October 29, 2014 4:05 PM MILAN—Against the backdrop of a strong third fiscal quarter, which saw increases in the company’s retail and wholesale division, worldwide, Luxottica Group said its board of directors, today, upon the chairman Leonardo Del Vecchio’s recent proposal, entrusted Massimo Vian, on an interim basis, with all executive responsibilities until Adil Mehboob-Khan joins Luxottica as co-CEO.

Novartis Reports Solid Sales Growth in 3Q 2014

By Staff
Wednesday, October 29, 2014 12:23 AM BASEL, Switzerland— Novartis (NVS: NYSE) delivered solid sales growth with strong margin expansion and major innovation in the third quarter ended Sept. 30, 2014.

Allergan Reports Historical Dollar Sales Gains for Q3

By Staff
Wednesday, October 29, 2014 12:14 AM IRVINE, Calif.—With net sales of $1,790.7 million for the third quarter ended Sept. 30, 2014, a 17.2 percent increase over net sales for the third quarter of 2013, Allergan, Inc. (NYSE: AGN) reported its “strongest increase in absolute dollar sales in any quarter in our history,” according to David E.I. Pyott, chairman and CEO, in a statement released by Allergan on Monday, Oct. 27, 2014.

Essilor 3Q ’14 Sales Up 14.5 Percent at Constant Exchange Rates

By Staff
Monday, October 27, 2014 12:23 AM CHARENTON-LE-PONT, France— Essilor International (Reuters: ESSI.PA) announced Friday that consolidated revenue for the third quarter of 2014, ending Sept. 30, climbed to €1,415 million, an increase of 14.5 percent, excluding the currency effect, over third quarter 2013.

Valeant Pharmaceuticals Reports Revenue Increase for Q3

By Staff
Wednesday, October 22, 2014 12:23 AM LAVAL, Quebec—Valeant Pharmaceuticals, Inc. (NYSE/TSX: VRX) reported its total revenue for the third fiscal quarter ended Sept. 30, 2014, was $2.1 billion, up 33 percent compared to the third quarter of 2014, with the U.S. and emerging market businesses contributing strong double-digit, same-store organic growth.

New Look Closes Purchase of Greiche & Scaff

By Staff
Wednesday, October 22, 2014 12:20 AM MONTREAL— New Look Eyewear Inc. ((TSX: BCI)), the Canadian optical retailer, completed its acquisition of certain optical assets and business forming part of Optic Direct Inc, carrying on business under the Greiche & Scaff banner in Quebec.

Johnson & Johnson’s 3Q Sales Rise 5.1 Percent

By Staff
Wednesday, October 15, 2014 12:23 AM NEW BRUNSWICK, N.J.—Boosted by a strong performance by its pharmaceutical business, Johnson & Johnson (NYSE: JNJ)  yesterday reported sales of $18.5 billion for the third quarter of 2014, an increase of 5.1 percent versus third quarter 2013.

RevolutionEHR Receives Financial Investment from RevOptix, Newly Formed Private Investment Group

By Staff
Friday, October 10, 2014 12:23 AM MADISON, Wis.—Earlier this week on Wednesday, Oct. 8, 2014, optometric software provider, RevolutionEHR received a financial investment from RevOptix, a newly formed private investment group headed by executive chairman Gunnar Bjorklund.

QLT Merger With Auxilium Pharmaceuticals, Inc. Is Terminated for Superior Proposal

By Staff
Friday, October 10, 2014 12:17 AM VANCOUVER, British Columbia— QLT Inc. (Nasdaq:QLTI) (TSX:QLT) said it has been advised by Auxilium Pharmaceuticals, Inc. that Auxilium's board of directors has reviewed an offer from Endo International plc to acquire all of the issued and outstanding shares of Auxilium.

Allergan Asks Court to Block Ackman Share Vote

By Staff
Wednesday, October 08, 2014 12:23 AM IRVING, Calif.— Allergan Inc. ((NYSE: AGN), which is continuing its efforts to fend off an unsolicited, $54 billion takeover bid by Valeant Pharmaceuticals International (NYSE: VRX), the parent company of Bausch + Lomb Inc., asked a judge to block Bill Ackman’s Pershing Square from voting at a shareholder meeting scheduled for December.

ZeaVision Receives Equity Investment From DSM Venturing

By Staff
Wednesday, October 08, 2014 12:20 AM ST. LOUIS— ZeaVision Holdings, Inc., supplier of nutritional supplements for eye health, has received an equity investment from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.

Unilens Net Income Up Over 100 Percent for Q4, Up About 15 Percent for Fiscal Year 2014

By Staff
Friday, October 03, 2014 12:23 AM LARGO, Fla.—Specialty contact lens supplier, Unilens Vision Inc.’s (OTCQX: UVIC) net income increased 115.3 percent to $277,636 in the fourth quarter ended June 30, 2014, when compared with net income of $128,960 during the comparable fourth quarter period of 2013, according to operating results just released by the company.

Unilens Vision Inc. Begins Trading on OTCQX Exchange

By Staff
Friday, September 26, 2014 12:23 AM LARGO, Fla.— Unilens Vision Inc.’s (OTCQX: UVIC) common stock has been approved to trade on the OTCQX exchange, described as “the best marketplace within OTC Markets Group [OTCQX: OTCM] for established U.S. and global companies,” according to a statement released yesterday by OTC Markets Group, the operator of the OTCQX, OTCQB and OTC Pink financial marketplaces.
Loading...